CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
59.72
0.90 (1.53%)
At close: Aug 15, 2025, 3:59 PM
60.00
0.47%
After-hours: Aug 15, 2025, 06:45 PM EDT
CRISPR Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 193.62M | 235.18M | 298.26M | 225.67M | 484.47M | 707.43M | 389.48M | 527.76M | 444.8M | 344.41M | 211.88M | 494.15M | 496.89M | 683.91M | 923.03M | 1.01B | 1.65B | 1.13B |
Short-Term Investments | 1.53B | 1.62B | 1.61B | 1.71B | 1.52B | 1.4B | 1.3B | 1.21B | 1.32B | 1.54B | 1.6B | 1.4B | 1.57B | 1.54B | 1.46B | 1.47B | 942.8M | 680.14M |
Long-Term Investments | n/a | n/a | n/a | n/a | 22.74M | 11.52M | 1.97M | 11.83M | 4.9M | 6.32M | 53.13M | 77.15M | 8.39M | 12.12M | 16.91M | 16.85M | 18.07M | 16.84M |
Other Long-Term Assets | 33.48M | 28.79M | 27.35M | 27.41M | 15.14M | 20.88M | 13.57M | 13.88M | 13.97M | 14.48M | 16.27M | 15.8M | 15.88M | 4.33M | 5.29M | 4.79M | 5.56M | 6.5M |
Receivables | n/a | n/a | 25M | n/a | n/a | n/a | 200M | n/a | 70M | n/a | n/a | 49K | 66K | 143K | 305K | 152K | 150K | 150K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 12.43M | 12.33M | 8.31M | 8.25M | 8.79M | 11.5M | 14.39M | 20.76M | 21.47M | 24.8M | 37.71M | 36.68M | 41.65M | 39.21M | n/a | 41.42M | 31.35M | 26.01M |
Total Current Assets | 1.73B | 1.87B | 1.94B | 1.94B | 2.01B | 2.12B | 1.91B | 1.76B | 1.86B | 1.91B | 1.85B | 1.93B | 2.11B | 2.26B | 2.42B | 2.52B | 2.62B | 1.83B |
Property-Plant & Equipment | 262.57M | 269.7M | 277.55M | 284.83M | 291.57M | 298.51M | 305.94M | 312.34M | 318.52M | 315.54M | 320.56M | 327.62M | 331.93M | 328.99M | 312.04M | 281.01M | 254.79M | 102.04M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | 2K | 16K | 30K | 43K | 57K | 71K | 84K | 98K | 112K | 125K | 139K | 153K | 167K |
Total Long-Term Assets | 296.05M | 298.49M | 304.9M | 312.24M | 329.45M | 319.39M | 321.49M | 326.24M | 337.44M | 336.4M | 390.03M | 420.65M | 356.31M | 345.56M | 334.36M | 302.79M | 278.58M | 125.55M |
Total Assets | 2.03B | 2.17B | 2.24B | 2.26B | 2.34B | 2.44B | 2.23B | 2.09B | 2.2B | 2.24B | 2.24B | 2.35B | 2.46B | 2.61B | 2.75B | 2.82B | 2.9B | 1.96B |
Account Payables | 9.75M | 13.06M | 14.71M | 15.58M | 9.45M | 16.46M | 38.15M | 26.15M | 27.59M | 45.15M | 27.43M | 27.84M | 25.24M | 27.11M | 14.82M | 10.17M | 10.14M | 13.07M |
Deferred Revenue | 2.13M | 3.02M | 3.85M | 4.48M | 4.76M | 4.07M | 4.11M | 3.5M | 12.32M | 12.32M | 12.32M | 12.32M | 12.32M | 12.32M | 1.01M | 1.56M | 2.07M | 1.8M |
Short-Term Debt | 18.03M | n/a | n/a | 16.88M | 16.45M | n/a | 15.63M | 15M | 14.83M | n/a | n/a | 11.26M | n/a | 11.08M | n/a | 12.64M | 15.88M | 12.06M |
Other Current Liabilities | 74.45M | n/a | 10.42M | 20.05M | 65.88M | 73.78M | 17.5M | 71.01M | 34.64M | 49.05M | 16.51M | 77.33M | 13.21M | 55.65M | 67.51M | 42.17M | 40.63M | 32.52M |
Total Current Liabilities | 104.36M | 119.45M | 87.78M | 89.81M | 127.82M | 118.99M | 108.79M | 111.23M | 132.84M | 146.79M | 121.11M | 150.87M | 119.96M | 113.7M | 119.88M | 96.21M | 99.92M | 83.09M |
Long-Term Debt | 197.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 16.8M | 3.32M | 3.44M | 3.68M | 3.65M | 3.62M | 958K | 5.39M | 5.48M | 5.8M | 5.97M | 5.31M | 6.09M | 7.33M | 7.34M | 8.09M | 8.7M | 8.14M |
Total Long-Term Liabilities | 214.22M | 217.5M | 222.17M | 226.66M | 231.08M | 236.09M | 237.98M | 247.8M | 248.15M | 242.67M | 246.47M | 248.53M | 252.57M | 247.56M | 232.53M | 212.6M | 195.8M | 69.32M |
Total Liabilities | 318.59M | 336.94M | 309.95M | 316.47M | 358.9M | 355.08M | 346.77M | 359.04M | 380.99M | 389.47M | 367.58M | 399.4M | 372.53M | 361.26M | 352.42M | 308.8M | 295.72M | 152.41M |
Total Debt | 215.45M | 219.36M | 223.69M | 227.54M | 231.3M | 234.93M | 238.63M | 241.59M | 245.18M | 240.27M | 244.02M | 242.16M | 242.43M | 238.98M | 225.03M | 205.38M | 191.2M | 61.47M |
Common Stock | 2.79M | 2.72M | 2.7M | 2.68M | 2.67M | 2.66M | 2.5M | 2.48M | 2.47M | 2.45M | 2.44M | 2.43M | 2.42M | 2.41M | 2.39M | 2.37M | 2.35M | 2.34M |
Retained Earnings | -1.71B | -1.5B | -1.37B | -1.33B | -1.24B | -1.12B | -999.7M | -1.09B | -976.89M | -899.15M | -846.09M | -735.51M | -560.97M | -375.13M | -195.91M | -54.67M | 72.49M | -686.74M |
Comprehensive Income | 4.04M | 4.13M | 1.84M | 10.56M | -2.88M | -1.55M | 1.91M | -6.8M | -8.91M | -9.39M | -15.65M | -22.26M | -20.34M | -16.89M | -5.07M | -770K | -629K | -461K |
Shareholders Equity | 1.71B | 1.83B | 1.93B | 1.94B | 1.98B | 2.08B | 1.88B | 1.73B | 1.82B | 1.85B | 1.88B | 1.95B | 2.09B | 2.24B | 2.4B | 2.51B | 2.6B | 1.81B |
Total Investments | n/a | 1.62B | 1.61B | 1.71B | 1.54B | 1.41B | 1.31B | 1.21B | 1.33B | 1.55B | 1.66B | 1.48B | 1.58B | 1.54B | 1.46B | 1.47B | 942.8M | 680.14M |